Literature DB >> 20957649

The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia.

Ryota Hashimoto1, Kazutaka Ohi, Yuka Yasuda, Motoyuki Fukumoto, Masao Iwase, Naomi Iike, Michiyo Azechi, Koji Ikezawa, Masahiko Takaya, Hidetoshi Takahashi, Hidenaga Yamamori, Tomo Okochi, Hitoshi Tanimukai, Shinji Tagami, Takashi Morihara, Masayasu Okochi, Toshihisa Tanaka, Takashi Kudo, Hiroaki Kazui, Nakao Iwata, Masatoshi Takeda.   

Abstract

A recent genome-wide association study showed that a variant (rs1344706) in the ZNF804A gene was associated with schizophrenia and bipolar disorder. Replication studies supported the evidence for association between this variant in the ZNF804A gene and schizophrenia and that this variant is the most likely susceptibility variant. Subsequent functional magnetic resonance imaging studies in healthy subjects demonstrated the association of the high-risk ZNF804A variant with neural activation during a memory task and a theory of mind task. As these cognitive performances are disturbed in patients with schizophrenia, this gene may play a role in cognitive dysfunction in schizophrenia. The aim of the current study was to investigate the potential relationship between this ZNF804A polymorphism and memory function. The effects of the high-risk ZNF804A genotype, diagnosis, and genotype-diagnosis interaction on verbal memory, visual memory (VisM), attention/concentration, and delayed recall (measured by the Wechsler Memory Scale-Revised) were analyzed by two-way analysis of covariance in 113 patients with schizophrenia and 184 healthy subjects. Consistent with previous studies, patients with schizophrenia exhibited poorer performance on all indices as compared to healthy control subjects (P < 0.001). A significant ZNF804A genotype-diagnosis interaction was found for VisM performance (P = 0.0012). Patients with the high-risk T/T genotype scored significantly lower on VisM than G carriers did (P = 0.018). In contrast, there was no genotype effect for any index in the healthy control subjects (P > 0.05). Our data suggest that rs1344706 may be related to memory dysfunction in schizophrenia. © 2010 Wiley-Liss, Inc.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20957649     DOI: 10.1002/ajmg.b.31123

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  23 in total

1.  Evidence of IQ-modulated association between ZNF804A gene polymorphism and cognitive function in schizophrenia patients.

Authors:  Min Chen; Zhansheng Xu; Jinguo Zhai; Xin Bao; Qiumei Zhang; Huang Gu; Qiuge Shen; Lina Cheng; Xiongying Chen; Keqin Wang; Xiaoxiang Deng; Feng Ji; Chuanxin Liu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2012-02-29       Impact factor: 7.853

2.  Zinc finger protein 804A (ZNF804A) and verbal deficits in individuals with autism.

Authors:  Ayyappan Anitha; Ismail Thanseem; Kazuhiko Nakamura; Mahesh M Vasu; Kazuo Yamada; Takatoshi Ueki; Yoshimi Iwayama; Tomoko Toyota; Kenji J Tsuchiya; Yasuhide Iwata; Katsuaki Suzuki; Toshiro Sugiyama; Masatsugu Tsujii; Takeo Yoshikawa; Norio Mori
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

3.  Differential effects of common variants in SCN2A on general cognitive ability, brain physiology, and messenger RNA expression in schizophrenia cases and control individuals.

Authors:  Dwight Dickinson; Richard E Straub; Joey W Trampush; Yuan Gao; Ningping Feng; Bin Xie; Joo Heon Shin; Hun Ki Lim; Gianluca Ursini; Kristin L Bigos; Bhaskar Kolachana; Ryota Hashimoto; Masatoshi Takeda; Graham L Baum; Dan Rujescu; Joseph H Callicott; Thomas M Hyde; Karen F Berman; Joel E Kleinman; Daniel R Weinberger
Journal:  JAMA Psychiatry       Date:  2014-06       Impact factor: 21.596

4.  Postnatal neurodevelopmental expression and glutamate-dependent regulation of the ZNF804A rodent homologue.

Authors:  Eric H Chang; Anne Kirtley; Toni-Shay S Chandon; Philip Borger; Sehba Husain-Krautter; Valerie Vingtdeux; Anil K Malhotra
Journal:  Schizophr Res       Date:  2015-07-08       Impact factor: 4.939

Review 5.  The global cognitive impairment in schizophrenia: consistent over decades and around the world.

Authors:  Jonathan Schaefer; Evan Giangrande; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2013-08-02       Impact factor: 4.939

6.  Individual risk alleles of susceptibility to schizophrenia are associated with poor clinical and social outcomes.

Authors:  Shinji Sakamoto; Manabu Takaki; Yuko Okahisa; Yutaka Mizuki; Masatoshi Inagaki; Hiroshi Ujike; Toshiharu Mitsuhashi; Soshi Takao; Masashi Ikeda; Yosuke Uchitomi; Nakao Iwata; Norihito Yamada
Journal:  J Hum Genet       Date:  2015-12-17       Impact factor: 3.172

7.  Influence of ZNF804a on brain structure volumes and symptom severity in individuals with schizophrenia.

Authors:  Thomas H Wassink; Eric A Epping; Danielle Rudd; Michael Axelsen; Stephen Ziebell; Frank W Fleming; Eric Monson; Beng Choon Ho; Nancy C Andreasen
Journal:  Arch Gen Psychiatry       Date:  2012-09

8.  Control of CNS functions by RNA-binding proteins in neurological diseases.

Authors:  Yijing Zhou; Fengping Dong; Yingwei Mao
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

Review 9.  Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy.

Authors:  Mark J Millan; Yves Agid; Martin Brüne; Edward T Bullmore; Cameron S Carter; Nicola S Clayton; Richard Connor; Sabrina Davis; Bill Deakin; Robert J DeRubeis; Bruno Dubois; Mark A Geyer; Guy M Goodwin; Philip Gorwood; Thérèse M Jay; Marian Joëls; Isabelle M Mansuy; Andreas Meyer-Lindenberg; Declan Murphy; Edmund Rolls; Bernd Saletu; Michael Spedding; John Sweeney; Miles Whittington; Larry J Young
Journal:  Nat Rev Drug Discov       Date:  2012-02-01       Impact factor: 84.694

10.  Effects of the CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy individuals.

Authors:  Hiroaki Hori; Noriko Yamamoto; Takashi Fujii; Toshiya Teraishi; Daimei Sasayama; Junko Matsuo; Yumiko Kawamoto; Yukiko Kinoshita; Miho Ota; Kotaro Hattori; Masahiko Tatsumi; Kunimasa Arima; Hiroshi Kunugi
Journal:  Sci Rep       Date:  2012-09-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.